Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system

Journal of Medicinal Chemistry

Volumn 49, Issue 15, 2006, Pages 4650-4656

  Saario, Susanna M ^a   Poso, Antti ^a   Juvonen, Risto O ^a   Järvinen, Tomi ^a   Salo Ahen, Outi M H ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; HTS 00798; HYDROLASE INHIBITOR; LIGAND; MWP 00348; SPB 01403; SPB 03742; SPB 07894; SPB 07951; TRIPOS 553110; TRIPOS 673991; TRIPOS 676019; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG SCREENING; ENZYME ASSAY; ENZYME INHIBITION; ENZYME MECHANISM; IC 50; MALE; MODEL; NONHUMAN; RAT;

AMIDOHYDROLASES; ANIMALS; BRAIN; DATABASES, FACTUAL; ENDOCANNABINOIDS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; MALE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MONOACYLGLYCEROL LIPASES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB2;

EID: 33746718652     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060394q     Document Type: Article

References (60)

1. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Hunger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946-1949.
2. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N. E.; Schatz, A. R.; Gopher, A.; Almog, S.; Martin, B. R.; Compton, D. R.; et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50, 83-90.
3. Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215, 89-97.
4. Di Marzo, V.; Fontana, A.; Cadas, H.; Schinelli, S.; Cimino, G.; Schwartz, J. C.; Piomelli, D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372, 686-691.
5. Schmid, P. C.; Zuzarte-Augustin, M. L.; Schmid, H. H. Properties of rat liver N-acylethanolamine amidohydrolase. J. Biol. Chem. 1985, 260, 14145-14149.
6. Deutsch, D. G.; Chin, S. A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 1993, 46, 791-796.
7. Cravatt, B. F.; Giang, D. K.; Mayfield, S. P.; Boger, D. L.; Lerner, R. A.; Gilula, N. B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996, 384, 83-87.
8. Dinh, T. P.; Kathuria, S.; Piomelli, D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol. Pharmacol. 2004, 66, 1260-1264.
9. Di Marzo, V.; Bisogno, T.; Sugiura, T.; Melck, D.; De Petrocellis, L. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem. J. 1998, 331 (Pt 1), 15-19.
10. Tornqvist, H.; Belfrage, P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J. Biol. Chem. 1976, 251, 813-819.
11. Jayamanne, A.; Greenwood, R.; Mitchell, V. A.; Asian, S.; Piomelli, D.; Vaughan, C. W. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br. J. Pharmacol. 2005.
12. Kathuria, S.; Gaetani, S.; Fegley, D.; Valino, F.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; La Rana, G.; Calignano, A.; Giustino, A.; Tattoli, M.; Palmery, M.; Cuomo, V.; Piomelli, D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 2003, 9, 76-81.
13. Deutsch, D. G.; Omeir, R.; Arreaza, G.; Salehani, D.; Prestwich, G. D.; Huang, Z.; Howlett, A. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem. Pharmacol. 1997, 53, 255-260.
14. Deutsch, D. G.; Lin, S.; Hill, W. A.; Morse, K. L.; Salehani, D.; Arreaza, G.; Omeir, R. L.; Makriyannis, A. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem. Biophys. Res. Commun. 1997, 231, 217-221.
15. Boger, D. L.; Sato, H.; Lerner, A. E.; Hedrick, M. P.; Fecik, R. A.; Miyauchi, H.; Wilkie, G. D.; Austin, B. J.; Patricelli, M. P.; Cravatt, B. F. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 5044-5049.
16. Boger, D. L.; Miyauchi, H.; Du, W.; Hardouin, C.; Fecik, R. A.; Cheng, H.; Hwang, I.; Hedrick, M. P.; Leung, D.; Acevedo, O.; Guimaraes, C. R.; Jorgensen, W. L.; Cravatt, B. F. Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics. J. Med. Chem. 2005, 48, 1849-1856.
17. Makara, J. K.; Mor, M.; Fegley, D.; Szabo, S. I.; Kathuria, S.; Astarita, G.; Duranti, A.; Tontini, A.; Tarzia, G.; Rivara, S.; Freund, T. F.; Piomelli, D. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat. Neurosci. 2005, 8, 1139-1141.
18. Saario, S. M.; Salo, O. M.; Nevalainen, T.; Poso, A.; Laitinen, J. T.; Jarvinen, T.; Niemi, R. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Chem. Biol. 2005, 12, 649-656.
19. Dinh, T. P.; Carpenter, D.; Leslie, F. M.; Freund, T. F.; Katona, I.; Sensi, S. L.; Kathuria, S.; Piomelli, D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 10819-10824.
20. Saario, S. M.; Savinainen, J. R.; Laitinen, J. T.; Jarvinen, T.; Niemi, R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem. Pharmacol. 2004, 67, 1381-1387.
21. Salo, O. M.; Raitio, K. H.; Savinainen, J. R.; Nevalainen, T.; Lahtela-Kakkonen, M.; Laitinen, J. T.; Jarvinen, T.; Poso, A. Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor. J. Med. Chem. 2005, 48, 7166-7171.
22. Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.; Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283-291.
23. Bifulco, M.; Laezza, C.; Valenti, M.; Ligresti, A.; Portella, G.; Di Marzo, V. A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. FASEB J. 2004, 18, 1606-1608.
24. Tervo, A. J.; Rönkkö, T.; Nyrönen, T. H.; Poso, A. BRUTUS: optimization of a grid-based similarity function for rigid-body molecular superposition. 1. Alignment and virtual screening applications. J. Med. Chem. 2005, 48, 4076-4086.
25. Rönkkö, T. P.; Tervo, A. J.; Parkkinen, J.; Poso, A. BRUTUS: Optimization of a grid-based similarity function for rigid-body molecular superposition. II. Description and characterization. J. Comput.-Aided Mol. Des. 2006, in press.
26. LeadQuest Compound Library, Tripos Associates, Inc.: St. Louis, MO. http://leadquest.tripos.com/.
27. Brickmann, J.; Goetze, T.; Heiden, W.; Moeckel, G.; Reiling, S.; Vollhardt, H.; Zachmann, C.-D., Interactive Visualization of Molecular Scenarios with MOLCAD/SYBYL. In Data Visualization in Molecular Science -Tools for Insight and Innovation, Bowie, J. E., Ed.; Addison-Wesley Publishing Company Inc.: Reading, MA, 1995; pp 83-97.
28. SYBYL v. 7.1. Tripos Associates, Inc.: St. Louis, MO. http://www.tripos.com/.
29. Giuffrida, A.; Parsons, L. H.; Kerr, T. M.; Rodriguez de Fonseca, F.; Navarro, M.; Piomelli, D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 1999, 2, 358-363.
30. Mentlein, R.; Suttorp, M.; Heymann, E. Specificity of purified monoacylglycerol lipase, palmitoyl-CoA hydrolase, palmitoyl-carnitine hydrolase, and nonspecific carboxylesterase from rat liver microsomes. Arch. Biochem. Biophys. 1984, 228, 230-246.
31. Tornqvist, H.; Belfrage, P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J. Biol. Chem. 1976, 251, 813-819.
32. Bracey, M. H.; Hanson, M. A.; Masuda, K. R.; Stevens, R. C.; Cravatt, B. F. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 2002, 298, 1793-1796.
33. Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M. C.; Estreicher, A.; Gasteiger, E.; Martin, M. J.; Michoud, K.; O'Donovan, C.; Phan, I.; Pilbout, S.; Schneider, M. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic. Acids Res. 2003, 31, 365-370.
34. Hofmann, B.; Tolzer, S.; Pelletier, I.; Altenbuchner, J.; van Pee, K. H.; Hecht, H. J. Structural investigation of the cofactor-free chloroperoxidases. J. Mol. Biol. 1998, 279, 889-900.
35. Berman, H. M.; Battistuz, T.; Bhat, T. N.; Bluhm, W. F.; Bourne, P. E.; Burkhardt, K.; Feng, Z.; Gilliland, G. L.; Iype, L.; Jain, S.; Fagan, P.; Marvin, J.; Padilla, D.; Ravichandran, V.; Schneider, B.; Thanki, N.; Weissig, H.; Westbrook, J. D.; Zardecki, C. The Protein Data Bank. Acta Crystallogr. D. Biol. Crystallogr. 2002, 58, 899-907.
36. InsightII v. 2000, Accelrys, Inc.: San Diego, CA. http://www.accelrys. com/.
37. SYBYL v. 6.9, Tripos Associates, Inc.: St. Louis, MO. http://www.tripos.com/.
38. Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ohio, C.; Alagona, G.; Profeta, S.; Weiner, J. P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 1984, 106, 765-784.
39. Weiner, S. J.; Kollman, P. A.; Nguyen, D. T.; Case, D. A. An all atom force field for simulations of proteins and nucleic acid. J. Comput. Chem. 1986, 11, 431-439.
40. Tsuboi, K.; Sun, Y. X.; Okamoto, Y.; Araki, N.; Tonai, T.; Ueda, N. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J. Biol. Chem. 2005, 280, 11082-11092.
41. Lindahl, E.; Hess, B.; van der Spoel, D. GROMACS 3.0: A package for molecular simulation and trajectory analysis. J. Mol. Model. 2001, 7, 306-317.
42. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926-935.
43. van Gunsteren, W. F.; Berendsen, H. J. C. Gromos-87 manual. Biomos BV Nijenborgh 4, 9747 AG Groningen, The Netherlands: 1987.
44. Essman, U.; Perela, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; Pedersen, L. G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995, 103, 8577-8592.
45. Berendsen, H. J. C.; Postma, J. P. M.; DiNola, A.; Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81, 3684-3690.
46. GOLD v. 2.0, Cambridge Crystallographic Data Centre: Cambrigde, U.K. http://www.ccdc.cam.ac.uk/products/life_sciences/gold/.
47. CScore, Tripos Associates, Inc.: St. Louis, MO. http://www.mpos. com/sciTech/inSilicoDisc/virtualScreening/cscore.html#references.
48. Ligresti, A.; Bisogno, T.; Matias, I.; De Petrocellis, L.; Cascio, M. G.; Cosenza, V.; D'Argenio, G.; Scaglione, G.; Bifulco, M.; Sorrentini, I.; Di Marzo, V. Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 2003, 125, 677-687.
49. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-748.
50. Halgren, T. A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 1996, 17, 490-519.
51. Halgren, T. A. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J. Comput. Chem. 1996, 17, 520-552.
52. Halgren, T. A. Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94. J. Comput. Chem. 1996, 17, 553-586.
53. Halgren, T. A.; Nachbar, R. B. Merck molecular force field. IV. conformational energies and geometries for MMFF94. J. Comput. Chem. 1996, 17, 587-615.
54. Halgren, T. A. Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules. J. Comput. Chem. 1996, 17, 616-641.
55. Halgren, T. A. MMFF VI. MMFF94s Option for Energy Minimization Studies. J. Comput. Chem. 1999, 20, 720-729.
56. Halgren, T. A. MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries. J. Comput. Chem. 1999, 20, 730-748.
57. Lorenzen, A.; Fuss, M.; Vogt, H.; Schwabe, U. Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5′-O-(3-[35S]thio) triphosphate binding. Mol. Pharmacol. 1993, 44, 115-123.
58. Kurkinen, K. M.; Koistinaho, J.; Laitinen, J. T. [Gamma-35S]GTP autoradiography allows region-specific detection of muscarinic receptor-dependent G-protein activation in the chick optic tectum. Brain Res. 1997, 769, 21-28.
59. Savinainen, J. R.; Jarvinen, T.; Laine, K.; Laitinen, J. T. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 2001, 134, 664-672.
60. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.